Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2025 = ×
Dec 31, 2024 = ×
Dec 31, 2023 = ×
Dec 31, 2022 = ×
Dec 31, 2021 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period under review demonstrates fluctuating performance in profitability and financial leverage. Return on Equity (ROE) exhibits significant volatility, influenced by concurrent changes in Return on Assets (ROA) and Financial Leverage. A general observation is that changes in ROA appear to have a more pronounced impact on ROE than changes in Financial Leverage.

Return on Assets (ROA)
ROA begins at 9.40% in 2021, decreases to 7.82% in 2023, experiences a substantial increase to 16.46% in 2024, and then declines again to 7.52% in 2025. This pattern suggests operational performance is subject to considerable variation. The peak in 2024 indicates a period of particularly efficient asset utilization, while the declines in 2023 and 2025 suggest reduced profitability relative to asset base.
Financial Leverage
Financial Leverage consistently declines over the observed period, moving from 2.10 in 2021 to 1.66 in 2025. This indicates a decreasing reliance on debt financing. The reduction is gradual, suggesting a deliberate strategy to lower financial risk or a shift in capital structure. While decreasing, the leverage remains above 1.0 for all periods, indicating the continued use of debt financing.
Return on Equity (ROE)
ROE mirrors the volatility seen in ROA, starting at 19.75% in 2021, falling to 14.83% in 2023, peaking at 28.12% in 2024, and then dropping sharply to 12.51% in 2025. The substantial increase in ROE in 2024 is directly correlated with the increase in ROA during the same period. The decline in 2025, despite continued decreasing leverage, is primarily driven by the decrease in ROA. This highlights the dominant influence of asset profitability on overall equity returns.

The interplay between ROA and Financial Leverage demonstrates that while decreasing leverage provides a degree of stability, the primary driver of ROE fluctuations is the efficiency with which assets are utilized to generate profit. Further investigation into the factors influencing ROA is warranted to understand the underlying causes of the observed volatility.


Three-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × ×
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period under review demonstrates fluctuating performance across key financial ratios impacting overall Return on Equity (ROE). A notable divergence in trends is observed, with significant shifts occurring between 2023 and 2024, followed by a return towards previous levels in 2025. The analysis below details the observed movements in Net Profit Margin, Asset Turnover, Financial Leverage, and their combined effect on ROE.

Net Profit Margin
The Net Profit Margin exhibited a declining trend from 16.42% in 2021 to 14.27% in 2023. A substantial increase was then recorded in 2024, reaching 31.95%, before decreasing to 14.72% in 2025. This volatility suggests significant changes in the company’s cost structure or pricing strategies during this period, with 2024 appearing as an outlier year.
Asset Turnover
Asset Turnover showed a modest increase from 0.57 in 2021 to 0.59 in 2022, followed by a gradual decline to 0.51 in 2025. This indicates a decreasing efficiency in utilizing assets to generate revenue over the observed timeframe. The rate of decline appears consistent, suggesting a systematic shift in asset management practices or industry conditions.
Financial Leverage
Financial Leverage consistently decreased from 2.10 in 2021 to 1.66 in 2025. This indicates a reduction in the company’s reliance on debt financing. While a lower leverage ratio generally reduces financial risk, it can also limit potential returns if not strategically managed.
Return on Equity (ROE)
ROE mirrored the fluctuations observed in the component ratios. It decreased from 19.75% in 2021 to 14.83% in 2023, experienced a dramatic increase to 28.12% in 2024, and then fell to 12.51% in 2025. The significant ROE increase in 2024 was primarily driven by the surge in Net Profit Margin, despite declines in Asset Turnover and Financial Leverage. The subsequent decline in 2025 reflects the combined impact of lower Net Profit Margin and continued decreases in Asset Turnover and Financial Leverage.

The DuPont analysis reveals that changes in Net Profit Margin were the primary driver of ROE fluctuations during the period. While Asset Turnover and Financial Leverage exhibited more consistent, albeit opposing, trends, their impact on ROE was less pronounced than that of the profit margin. The substantial increase and subsequent decrease in Net Profit Margin warrant further investigation to understand the underlying factors contributing to these shifts.


Five-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × × × ×
Dec 31, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Dec 31, 2021 = × × × ×

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The five-component DuPont analysis reveals fluctuating performance over the observed period. Return on Equity (ROE) experienced significant volatility, beginning at 19.75% in 2021, declining to 14.83% in 2023, peaking at 28.12% in 2024, and then decreasing substantially to 12.51% in 2025. This fluctuation warrants further investigation into the underlying drivers.

Profitability (EBIT Margin)
The EBIT Margin demonstrated relative stability between 2021 and 2023, hovering around 20.3% before decreasing to 18.05% in 2024. A recovery to 20.21% is observed in 2025, suggesting a potential rebound in operational efficiency or pricing power. The overall trend indicates a moderate level of profitability with a recent improvement.
Efficiency (Asset Turnover)
Asset Turnover exhibited a consistent downward trend throughout the period, decreasing from 0.57 in 2021 to 0.51 in 2025. This indicates a declining ability to generate sales from its asset base, potentially signaling inefficiencies in asset utilization or a shift in business strategy. The consistent decline is a point of concern.
Financial Leverage
Financial Leverage decreased steadily from 2.10 in 2021 to 1.66 in 2025. This suggests a reduction in the company’s reliance on debt financing. While decreasing leverage can reduce financial risk, it may also limit the potential for amplified returns when profitability is strong.
Tax Burden
The Tax Burden fluctuated considerably. It began at 0.86 in 2021, decreased to 0.83 in 2022, returned to 0.86 in 2023, increased sharply to 1.91 in 2024, and then decreased to 0.77 in 2025. This volatility suggests changes in tax rates, tax planning strategies, or the geographic distribution of profits. The significant increase in 2024, followed by a decrease in 2025, is particularly noteworthy.
Interest Burden
The Interest Burden remained relatively stable throughout the period, fluctuating between 0.91 and 0.94. This consistency suggests a stable cost of debt and effective management of interest-bearing liabilities. The minimal variation indicates a predictable interest expense profile.

The substantial increase in ROE in 2024, coupled with the high Tax Burden in the same year, suggests a potentially unusual event or accounting adjustment significantly impacting net income. The subsequent decline in ROE in 2025, despite an improved EBIT Margin, is likely attributable to the combined effects of decreasing Asset Turnover, reduced Financial Leverage, and a lower Tax Burden. Further investigation is recommended to understand the drivers behind these fluctuations and their implications for future performance.


Two-Component Disaggregation of ROA

Abbott Laboratories, decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2025 = ×
Dec 31, 2024 = ×
Dec 31, 2023 = ×
Dec 31, 2022 = ×
Dec 31, 2021 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period under review demonstrates fluctuating performance in profitability and efficiency. Return on Assets (ROA) experienced volatility, influenced by concurrent movements in Net Profit Margin and Asset Turnover. A detailed examination of these components reveals key insights into the observed ROA trends.

Net Profit Margin
Net Profit Margin exhibited a declining trend from 16.42% in 2021 to 14.27% in 2023. A significant increase was then observed in 2024, reaching 31.95%, before receding to 14.72% in 2025. This suggests substantial, though potentially non-recurring, improvements in profitability in 2024. The return to a level closer to 2023’s margin in 2025 indicates that the 2024 performance may not be sustainable at that level.
Asset Turnover
Asset Turnover showed a modest increase from 0.57 in 2021 to 0.59 in 2022, followed by a consistent decline to 0.51 in 2025. This indicates a gradual decrease in the efficiency with which assets are utilized to generate sales. The decline in asset turnover is relatively consistent, suggesting a systematic factor impacting sales generation relative to the asset base.
Return on Assets (ROA)
ROA generally tracked the Net Profit Margin trend, with a decrease from 9.40% in 2021 to 7.82% in 2023. The substantial increase in Net Profit Margin in 2024 drove a corresponding increase in ROA to 16.46%. However, the subsequent decline in Net Profit Margin in 2025, coupled with the continued decrease in Asset Turnover, resulted in a decrease in ROA to 7.52%. The ROA performance is heavily influenced by the volatility of the Net Profit Margin.

The interplay between Net Profit Margin and Asset Turnover is evident in the ROA fluctuations. While improvements in profitability, as seen in 2024, can significantly boost ROA, sustained ROA performance requires both strong profitability and efficient asset utilization. The observed decline in Asset Turnover warrants further investigation to identify the underlying causes and potential mitigation strategies.


Four-Component Disaggregation of ROA

Abbott Laboratories, decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2025 = × × ×
Dec 31, 2024 = × × ×
Dec 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Dec 31, 2021 = × × ×

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period demonstrates fluctuating performance across key financial metrics. Return on Assets (ROA) experienced significant volatility, while the components contributing to ROA – EBIT Margin, Asset Turnover, Interest Burden, and Tax Burden – exhibited distinct trends. A notable increase in ROA occurred in 2024, followed by a decline in 2025.

EBIT Margin
The EBIT Margin remained relatively stable between 2021 and 2023, fluctuating around 20.30% and decreasing to 18.20% in 2023. A slight further decrease to 18.05% was observed in 2024, before a substantial recovery to 20.21% in 2025. This suggests improving operational efficiency or pricing power in the most recent year.
Asset Turnover
Asset Turnover exhibited a consistent downward trend throughout the period. Starting at 0.57 in 2021, it decreased to 0.51 by 2025. This indicates a declining ability to generate sales from its asset base, potentially due to increased asset holdings without a corresponding increase in revenue, or a decrease in sales.
Interest Burden
The Interest Burden remained remarkably stable across all years, consistently around 0.94, with a minor dip to 0.91 in 2023 and a slight increase to 0.93 in 2024. This suggests consistent financial leverage and relatively stable interest expenses.
Tax Burden
The Tax Burden showed considerable fluctuation. It began at 0.86 in 2021, decreased to 0.83 in 2022, returned to 0.86 in 2023, then increased sharply to 1.91 in 2024, before decreasing significantly to 0.77 in 2025. This volatility likely reflects changes in tax rates, tax credits, or the geographic distribution of earnings.

The substantial increase in ROA in 2024 was primarily driven by a significant jump in the Tax Burden, despite a slight decrease in EBIT Margin and Asset Turnover. The subsequent decline in ROA in 2025, despite an improved EBIT Margin, was attributable to a decrease in the Tax Burden and continued decline in Asset Turnover. The interplay between these components highlights the sensitivity of overall profitability to tax-related factors and asset utilization efficiency.

Overall, the period was characterized by a complex interaction of factors influencing ROA. While the EBIT Margin demonstrated resilience, the declining Asset Turnover presents a potential area of concern. The significant fluctuations in the Tax Burden underscore the importance of considering tax implications when evaluating financial performance.


Disaggregation of Net Profit Margin

Abbott Laboratories, decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2025 = × ×
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period under review demonstrates significant fluctuations in profitability metrics, particularly concerning net profit margin. A disaggregation of factors influencing this margin reveals notable shifts in tax and interest burdens, alongside changes in core operating profitability as measured by the EBIT margin.

Net Profit Margin
Net profit margin experienced a decline from 16.42% in 2021 to 14.27% in 2023. However, a substantial increase was observed in 2024, reaching 31.95%, before receding to 14.72% in 2025. This volatility suggests the presence of non-recurring items or significant changes in the company’s financial structure impacting net income.
EBIT Margin
The EBIT margin exhibited relative stability between 2021 and 2023, fluctuating within a narrow range of 20.30% to 18.20%. A slight decrease continued into 2024, reaching 18.05%, followed by a recovery to 20.21% in 2025. This indicates core operational profitability remained reasonably consistent, with a recent positive trend.
Tax Burden
The tax burden remained relatively stable between 2021 and 2023, ranging from 0.83 to 0.86. A significant spike occurred in 2024, with the tax burden reaching 1.91, likely contributing to the lower net profit margin observed in that year. The tax burden then decreased substantially to 0.77 in 2025, partially offsetting the impact on net income.
Interest Burden
The interest burden demonstrated considerable consistency throughout the period, remaining close to 0.94. Minor fluctuations were observed, but these did not appear to have a substantial impact on net profit margin. This suggests that changes in debt levels or interest rates were not primary drivers of the observed profitability trends.

The substantial increase in net profit margin in 2024, coupled with the corresponding surge in tax burden, suggests a potential one-time gain or accounting adjustment that significantly impacted taxable income. The subsequent decline in both net profit margin and tax burden in 2025 indicates a return to more typical profitability levels. Further investigation into the specific factors driving these changes is warranted.